Notes
Among the new users of PPIs, almost 59% of all initial PPI prescriptions were for rabeprazole 20mg once daily, almost 22% were for omeprazole 20mg once daily, and approximately 8% were for rabeprazole 20mg twice daily.
Reference
Xie Y, et al. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study. BMJ 365: [13 pages], 30 May 2019. Available from: URL: https://doi.org/10.1136/bmj.l1580
Rights and permissions
About this article
Cite this article
Deaths linked with new use of PPIs assessed in US veterans. Reactions Weekly 1756, 3 (2019). https://doi.org/10.1007/s40278-019-62882-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-62882-z